This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

Forward Look: Top Regulatory Midyear Trends for 2014 in Life Sciences


Life Sciences Midyear Outlook

Although the life sciences regulatory environment continues to evolve, the general direction seems to be toward increased compliance requirements, scrutiny and enforcement. The six regulatory trends highlighted below are likely to have a significant impact on the life sciences industry for the rest of 2014 – and beyond.

  • Patient safety and enforcement
  • Increasing emphasis on transparency
  • Greater collaboration between regulatory and businesses
  • Accelerated product approvals
  • Technology
  • Secure supply chain

This white paper explores the implications behind these trends and steps life sciences companies can consider in order to construct an effective regulatory agenda. The overarching challenge for life sciences companies will be finding ways to achieve compliance without creating excessive drag on the business.

As used in this document, "Deloitte" means Deloitte LLP and its subsidiaries. Please see for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.

Related links

Share this page

Email this Send to LinkedIn Send to Facebook Tweet this More sharing options

Stay connected